CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Alnylam Pharmaceuticals, Inc. Company Snapshot
Alnylam Pharmaceuticals, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Alnylam Pharmaceuticals with three other companies in this sector in the United States: Theravance Biopharma Inc (2016 sales of $48.65 million of which 100% was Human Therapeutics), Reliv' International, Inc. ($45.51 million ), and China Yct International Group, Inc. ($47.83 million ).

Sales Analysis. During the year ended December of 2016, sales at Alnylam Pharmaceuticals were $47.16 million. This is an increase of 14.8% versus 2015, when the company's sales were $41.10 million. Despite this increase, sales are still below the level achieved in 2014, when Alnylam Pharmaceuticals reported sales of $50.56 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Alnylam Pharmaceuticals, Inc.
  Stock Performance Chart for Alnylam Pharmaceuticals, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (6/23/2017): 85.21
(Figures in U.S. Dollars)
1 Week 12.0%   13 Weeks 29.5%  
4 Weeks 62.4%   52 Weeks 56.9%  
 
Alnylam Pharmaceuticals, Inc. Key Data:
  Ticker: ALNY Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 47,159,000
(Year Ending Jan 2017).
Employees: 165
  Currency: U.S. Dollars Market Cap: 7,795,666,321
  Fiscal Yr Ends: December Shares Outstanding: 91,487,693
  Share Type: Common Closely Held Shares: 14,935,759
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.